Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer

International Journal of Gynecological Cancer

Volumn 17, Issue 4, 2007, Pages 890-896

  Suzuki, R ^a   Miyagi, E ^a   Takahashi, N ^a   Sukegawa, A ^a   Suzuki, A ^a   Koike, I ^a   Sugiura, K ^a   Okamoto, N ^b   Inoue, T ^a   Hirahara, F ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

Endometrial cancer; FDG PET; Preoperative diagnosis

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34447302068     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00859.x     Document Type: Article

References (19)

1. Nakamoto Y, Saga T, Fujii S. Positron emission tomography application for gynecologic tumors. Int J Gynecol Cancer 2005 15: 701 9.
2. Singh AK, Grigsby PW, Dehdashti F et al. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int J Radiat Oncol Biol Phys 2003 56: 489 93.
3. Lin WC, Hung YC, Yeh LS et al. Usefulness of 18F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 2003 89: 73 6.
4. Grigsby PW, Siegel BA, Dehdashti F et al. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001 19: 3745 9.
5. Rose PG, Adler LP, Rodriguez M et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 1999 17: 41 5.
6. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001 218: 776 82.
7. Tran BN, Grigsby PW, Dehdashti F et al. Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix. Gynecol Oncol 2003 90: 572 6.
8. Nakamoto Y, Eisbruch A, Achtyes ED et al. Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. Gynecol Oncol 2002 84: 289 95.
9. Belhocine T, Thille A, Fridman V et al. Contribution of whole-body 18FDG PET imaging in the management of cervical cancer. Gynecol Oncol 2002 87: 90 7.
10. Kumar R, Alavi A. PET imaging in gynecologic malignancies. Radiol Clin North Am 2004 42: 1155 67.
11. Zimny M, Siggelkow W, Schroder W et al. 2-[Fluorine-18]-fluoro-2-deoxy-D- glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 2001 83: 310 5.
12. Rose PG, Faulhaber P, Miraldi F et al. Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy. Gynecol Oncol 2001 82: 17 21.
13. Makhija S, Howden N, Edwards R, Kelley J, Townsend DW, Meltzer CC. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol 2002 85: 53 8.
14. Suzuki A, Kawano T, Takahashi N et al. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging 2004 31: 1413 20.
15. Nakahara T, Fujii H, Ide M et al. F-18 FDG uptake in endometrial cancer. Clin Nucl Med 2001 26: 82 3.
16. Umesaki N, Tanaka T, Miyama M et al. Positron emission tomography with 18F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 2001 80: 372 7.
17. Belhocine T, Barsy C, Hustinx R et al. Usefulness of 18F-FDG PET in the post therapy surveillance of endometrial carcinoma. Eur J Nucl Med 2002 29: 1132 9.
18. Saga T, Higashi T, Ishimori T et al. Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med 2003 17: 197 203.
19. Horowitz NS, Dehdashti F, Herzog J et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 2004 95: 546 51.